These trials aimed to evaluate its ability to lower serum uric acid levels, reduce gout flares, and provide anti-inflammatory effects
Its defining property is receptor selectivity at typical research doses it produces minimal cortisol, prolactin, or ACTH elevation, distinguishing it from earlier GHRPs like GHRP-6 or GHRP-2
Although IN delivery of DFO appears to be well tolerated in animal models, repeated administration can potentially cause nasal irritation or epistaxis (nosebleed), which can induce inflammation or reduced drug uptake
But results depend on where you get treated
The KLOW blend contains four synthetic peptides: BPC-157 at 50mg, TB-500 at 10mg, KPV (Lys-Pro-Val) at 10mg, and GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) at 10mg 80mg total in 3mL